NT-175
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NT-175, covering 2026-04-15 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation [Phase 1]